These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Taylor AL; Marcus R; Bradley JA Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320 [TBL] [Abstract][Full Text] [Related]
7. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient. Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468 [TBL] [Abstract][Full Text] [Related]
9. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094 [TBL] [Abstract][Full Text] [Related]
10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965 [TBL] [Abstract][Full Text] [Related]
11. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Ranganathan S; Webber S; Ahuja S; Jaffe R Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542 [TBL] [Abstract][Full Text] [Related]
12. Is there a difference between Hodgkin's disease and a Hodgkin's-like post-transplant lymphoproliferative disorder, and why should that be of any interest? Ranganathan S; Jaffe R Pediatr Transplant; 2004 Feb; 8(1):6-8. PubMed ID: 15009835 [No Abstract] [Full Text] [Related]
13. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report. Johnson J; Kerecuk L; Harrison M; Taylor JO; Odell E Pediatr Transplant; 2007 May; 11(3):340-4. PubMed ID: 17430495 [TBL] [Abstract][Full Text] [Related]
15. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center]. Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748 [TBL] [Abstract][Full Text] [Related]